| TO: |
Editors and Reporters
|
| FROM: |
National Institute of Diabetes and Digestive and Kidney Diseases,
National Cancer Institute, National Institute on Drug Abuse, National
Institute of Allergy and Infectious Diseases, and Office of Research
on Minority Health, National Institutes of Health (NIH)
|
| WHAT: |
"HEPATITIS C in AFRICAN-AMERICANS," an NIH workshop |
| WHEN: |
December 2, 1999, 8:30 to 5:30 p.m. |
| WHERE: |
Lister Hill Auditorium, Bethesda, MD |
| WHY: |
Nearly 4 million Americans are infected with hepatitis C. African-
Americans suffer the highest incidence and prevalence rates
for the disease among all racial and ethnic groups in the United
States. The NIDDK and other NIH institutes are bringing together
experts to discuss the current knowledge on the prevalence, clinical
course, complications, and treatment of hepatitis C in African-
Americans. Participants will also discuss future research needs and
ways to get more African-Americans involved in hepatitis C clinical
trials.
|
